Skip to Content

Acyclovir topical Pregnancy and Breastfeeding Warnings

Acyclovir topical is also known as: Zovirax Cream, Zovirax Ointment

Acyclovir topical Pregnancy Warnings

This drug was not teratogenic in mouse, rabbit, or rat at exposures greatly more than human exposure. In a review of 229,101 deliveries to Michigan Medicaid patients, 391 first trimester exposures to acyclovir and 1081 exposures any time during pregnancy were recorded. These exposures included systemic and nonsystemic exposures. A total of 18 birth defects were reported with first trimester exposure (17 expected) and included (observed/expected) 5/4 cardiovascular defects, 1 polydactyly, and limb reductions (Written communication, Franz Rosa, MD, Food and Drug Administration, 1994). There are no controlled data in human pregnancy. AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans. US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

Benefit should outweigh risk AU TGA pregnancy category: B3 US FDA pregnancy category: B

See references

Acyclovir topical Breastfeeding Warnings

Use is generally considered acceptable Excreted into human milk: Yes Comments: Women with active herpetic lesions near or on the breast should avoid nursing.

Systemic exposure following oral administration is low suggesting topical use may be insignificant. Women with active herpetic lesions near or on the breast should avoid nursing; topical use to small areas of the mother's body away from the breast should pose no risk to the infant. Water-miscible cream or gel product applied to the breast as ointments may expose infant to high levels of mineral paraffins via licking.

See references

References for pregnancy information

  1. "Product Information. Zovirax Topical (acyclovir topical)." Valeant Pharmaceuticals, Costa Mesa, CA.

References for breastfeeding information

  1. "Product Information. Zovirax Topical (acyclovir topical)." Valeant Pharmaceuticals, Costa Mesa, CA.
  2. United States National Library of Medicine "Toxnet. Toxicology Data Network. Available from: URL:" ([cited 2013 -]):

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.